# Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

> clinical trial · VERIFIED · 2026-08-12

Status: RECRUITING · Sponsor: Blueprint Medicines Corporation · Condition: Clonal Mast Cell Disease

- Company: Blueprint Medicines Corporation
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT07143669

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.